FindTrial
Sign In

IL-10

DIAGNOSTIC_TEST3 trials

Sponsors

Renovo Ltd, Merck Sharp & Dohme LLC, NHS Greater Glasgow and Clyde

Conditions

Bile Duct DiseasesBiliary Tract DiseasesGallbladder DiseasesHeart FailureMyocarditisPancreatic DiseasesPancreatitisPrevention and reduction of scarring MedDRA version: 6.1 Level: PT Classification code 10039580

Phase 2

Safety and Efficacy Study of IL-10 (Tenovil TM) in the Prevention of Post-ERCP Acute Pancreatitis (Study P02580)(TERMINATED)
TerminatedNCT00040131
Merck Sharp & Dohme LLCBile Duct Diseases, Biliary Tract Diseases, Gallbladder Diseases +2
Start: 2002-01-31End: 2003-01-31Updated: 2015-11-02
A single centre, placebo and standard care controlled, double blind, randomised, trial to investigate the efficacy of eight doses of RN1003 in the reduction of scarring from approximated wound margins of incisional wounds - RN1002 - 0027
Active, not recruitingEUCTR2004-001455-11-GB
Renovo LtdPrevention and reduction of scarring MedDRA version: 6.1 Level: PT Classification code 10039580
Start: 2006-04-03Target: 175Updated: 2019-11-25

Unknown Phase

CharacterisatiON of carDiac funCTion in Intensive Care Unit Survivors of Sepsis.
NCT05633290
NHS Greater Glasgow and ClydeHeart Failure, Myocarditis, Sepsis +1
Start: 2023-03-01End: 2024-02-29Target: 69Updated: 2023-03-08

Related Papers

Characterizing Cardiac Function in ICU Survivors of Sepsis
CHEST Critical Care2024-01-242 citations